Gutierrez, M.D., an endocrinologist and associate professor of endocrinology at McGovern Medical School at UTHealth in Houston, Texas
In OASIS 4, 74% of participants experienced gastrointestinal side effects, compared to 42% on placebo
Taranta A, Elmonem MA, Bellomo F, De Leo E, Boenzi S, Janssen MJ, Jamalpoor A, Cairoli S, Pastore A, De Stefanis C, Colucci M, Rega LR, Giovannoni I, Francalanci P, van den Heuvel LP, Dionisi-Vici C, Goffredo BM, Masereeuw R, Levtchenko E, Emma F (2021) Benefits and toxicity of disulfiram in preclinical models of nephropathic cystinosis
But because they change how much you eat and how long food remains in your stomach, its important that you adapt your diet accordingly
CJC1295 + Ipamorelin CJC-1295 with Ipamorelin is a combination peptide therapy designed to enhance growth hormone production in the body